Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
about
Citalopram versus other anti-depressive agents for depressionChanges in body weight and psychotropic drugs: a systematic synthesis of the literatureDoes adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Incomplete response in late-life depression: getting to remissionDouble-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder.Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.Physical activity in depressed elderly. A systematic review.Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review.Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients.Pharmacotherapy for late-life depression.Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate.Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI.A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials.Assessing bipolar disorder in the older adult: the GERI-BD toolbox.
P2860
Q24202141-E59A32F4-4FD7-43AD-9C17-4A589C21F034Q28728401-2C502921-47D1-4498-A205-5BF67F9AD10EQ34355963-271D6D34-D5C7-4EB1-B720-3CDF58C4127DQ35057288-0CB1E3C1-D542-47C2-89E4-7863CBBFA861Q35237063-F9F25589-C999-458A-8111-6572FAA95305Q35964362-31628B36-6F20-46F4-B759-884292733047Q36403127-67F2AF2D-CCD0-4CC7-B35C-65AC37D9797EQ37136799-32E9B017-667E-4F50-8425-B6644DF73980Q38753966-4FC7D4AA-0F17-48C2-A3DE-14DFA8D19E0FQ40493760-C30F69C4-1038-4E0A-84A8-37F5B0D6F00EQ41869145-36305904-7CB1-485C-874C-8D3936347173Q43848135-A29CDFC3-C10D-46FA-954F-33FD1B334455Q46236786-D35E2540-C045-40C7-9B16-5F77694E003EQ47165527-12F587D8-E77A-4928-86AE-4AF777272390Q47876421-A29EE61F-5AE2-4EE0-9B91-DFAD33A60948
P2860
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Efficacy and tolerability of v ...... arative trial with citalopram.
@en
Efficacy and tolerability of v ...... arative trial with citalopram.
@nl
type
label
Efficacy and tolerability of v ...... arative trial with citalopram.
@en
Efficacy and tolerability of v ...... arative trial with citalopram.
@nl
prefLabel
Efficacy and tolerability of v ...... arative trial with citalopram.
@en
Efficacy and tolerability of v ...... arative trial with citalopram.
@nl
P2093
P2860
P356
P1476
Efficacy and tolerability of v ...... arative trial with citalopram.
@en
P2093
Jesper Søgaard
Kirsten Behnke
Kristina Timdahl
Martin Hanson
Per Allard
P2860
P304
P356
10.1002/GPS.1190
P407
P577
2004-12-01T00:00:00Z